The Ragon BSL3 core provides biosafety level-3 laboratory space, training, and consultation for academic and industrial researchers working with risk group-3 pathogens, such as M. tuberculosis, SARS-CoV-2, Chikungunya virus, West Nile virus, Powassan virus, Japanese Encephalitis virus, Dabie bandavirus, Heartland virus and Bhanja virus.
Researchers are required to complete 30 hours of BSL3 specific training to become certified BSL3 core users. Training covers special facility containment, BSL-3 specific PPE, and safety regulations specific to risk group-3 pathogens.
Ragon BSL3 core users from the Gehrke lab (MIT)
Ragon BSL3 director and co-director
Ragon BSL3 user working in biosafety cabinet
Ragon BSL3 core users from the Goldfeld & Lieberman lab (Boston Children's Hospital) and BSL3 co-director
The Ragon BSL3 is one of the largest (2200 square feet) and most heavily used BSL3 facility in the region, with an excellent safety track record. The lab is equipped with dedicated 12-color high-speed cell sorter and microscopy equipment, as well as cell culture hoods and standard cell and molecular biology resources.
Learn MoreYonker LM, Boucau J, Regan J, Choudhary MC, Burns MD, Young N, Farkas EJ, Davis JP, Moschovis PP, Bernard Kinane T, Fasano A, Neilan AM, Li JZ, Barczak AK
J Infect Dis . 2021 Dec 1;224(11) PubMed
Siedner MJ, Boucau J, Gilbert RF, Uddin R, Luu J, Haneuse S, Vyas T, Reynolds Z, Iyer S, Chamberlin GC, Goldstein RH, North CM, Sacks CA, Regan J, Flynn JP, Choudhary MC, Vyas JM, Barczak AK, Lemieux JE, Li JZ
JCI Insight . 2022 Jan 25;7(2):e155483 PubMed
Boucau J, Chew KW, Choudhary M, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, Li JZ, Barczak AK; ACTIV-2/A5401 Study Team.
medRxiv . 2021 Dec 30;2021.12.25.21268211. doi: 10.1101/2021.12.25.21268211 PubMed
Choi B, Choudary M, Regan J, Sparks JA, Padera RF Jr, Qiu X, Solomon I, Kuo HH, Boucau J, Bowman KA, Das Adhikari U, Winkler ML, Mueller AM, Hsu TY, Desjardins M, Baden L, Chan B, Walker BD, Lichterfeld MD, Brigl M, Kwon DK, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha G, Seaman M, Cernadas M, Li J
New England Journal of Medicine 2020 Dec 3; 383(23) PubMed
North CM, Barczak AK, Goldstein RH, Healy B, Finkelstein DM, Ding D, Kim J, Boucau J, Shaw B, Gilbert B, Vyas T, Reynolds Z, Regan J, Flynn J, Choudary M, Vyas J, Laskowski K, Dighe A, Lemieux J, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA
Clinical Infectious Disease 2021 Aug 7 PubMed
